These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14513254)

  • 61. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) with fever induced by oral cloxacillin: does fever confound the diagnosis?
    Chong WS; Lim HL
    J Dermatol; 2010 Sep; 37(9):830-2. PubMed ID: 20883371
    [No Abstract]   [Full Text] [Related]  

  • 62. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
    Mukherjee S
    J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
    [No Abstract]   [Full Text] [Related]  

  • 63. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.
    Ketikoglou I; Karatapanis S; Elefsiniotis I; Kafiri G; Moulakakis A
    Eur J Dermatol; 2005; 15(2):107-9. PubMed ID: 15757824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
    Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
    [No Abstract]   [Full Text] [Related]  

  • 65. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 66. [Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].
    Virolés Torrent S; López Nuñez C; Hombrados Verde M; Figa Francesch M; Ferri Iglesias MJ; Louvriex Freire R; Acero Fernández D
    Gastroenterol Hepatol; 2015 Feb; 38(2):78-81. PubMed ID: 24948444
    [No Abstract]   [Full Text] [Related]  

  • 67. [Acute generalized exanthematous pustulosis induced by carbimazole (Neomercazole): first reported case and value of patch tests].
    Grange-Prunier A; Roth B; Kleinclaus I; Fagot JP; Guillaume JC
    Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):708-10. PubMed ID: 17053748
    [No Abstract]   [Full Text] [Related]  

  • 68. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.
    Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
    Gut; 2006 Nov; 55(11):1682-3. PubMed ID: 17047132
    [No Abstract]   [Full Text] [Related]  

  • 69. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
    [No Abstract]   [Full Text] [Related]  

  • 70. Pegylated interferon associated lichen planus at the injection site.
    Ergül B; Koçak E; Akbal E; Köklü S; Astarci HM
    Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
    [No Abstract]   [Full Text] [Related]  

  • 71. Rapid development of severe thrombocytopenia in a female with chronic hepatitis C after single-dose pegylated interferon therapy.
    Huang HH; Lin CF; Shih YL; Chang WK; Hsieh TY
    Dig Liver Dis; 2010 Mar; 42(3):233-4. PubMed ID: 19592316
    [No Abstract]   [Full Text] [Related]  

  • 72. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
    van Zonneveld M; Flink HJ; Verhey E; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Hansen BE; Schalm SW; Janssen HL;
    Aliment Pharmacol Ther; 2005 May; 21(9):1163-71. PubMed ID: 15854180
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
    di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
    J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
    [No Abstract]   [Full Text] [Related]  

  • 74. Pure red cell aplasia following pegylated interferon alpha treatment.
    Arcasoy MO; Rockey DC; Heneghan MA
    Am J Med; 2004 Oct; 117(8):619-20. PubMed ID: 15465516
    [No Abstract]   [Full Text] [Related]  

  • 75. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege.
    Ito T; Suzuki T; Funakoshi A; Tokura Y
    Eur J Dermatol; 2014; 24(5):631-3. PubMed ID: 25115439
    [No Abstract]   [Full Text] [Related]  

  • 76. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 77. Interstitial pneumonitis after treatment for hepatitis C virus infection.
    Botnaru V; Munteanu O; Rusu D
    Pneumologia; 2015; 64(1):46-50. PubMed ID: 26016056
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
    Ozkurt ZN; Sucak GT; Aki SZ; Yağci M; Erdem O
    Cutan Ocul Toxicol; 2009; 28(3):141-3. PubMed ID: 19548772
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rash and fever in a 14-month-old girl.
    Kepley JM; Bowen C; Kobayashi T
    J Fam Pract; 2015 May; 64(5):E1-3. PubMed ID: 26009749
    [No Abstract]   [Full Text] [Related]  

  • 80. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C.
    Colomba C; Rubino R; Siracusa L; Mazzola G; Titone L
    J Antimicrob Chemother; 2012 Jan; 67(1):249-50. PubMed ID: 21965434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.